Rare diseases are usually caused by a single genetic defect, but searching for the cause and assessing the effects of those defects is highly complex and difficult. Researchers headed by a team at the ...

Revolune today announced the commercial availability of its multiplex immunofluorescence reagent portfolio and the official start of its commercialization journey. The milestone marks the company's ...

At Harvard University’s Longwood campus, synthetic biologist and geneticist George Church finds himself busy. If he’s not guiding his students in building the latest biotech prototypes, he’s ...